115 related articles for article (PubMed ID: 27283888)
1. Down-regulated and Commonly mutated ALPK1 in Lung and Colorectal Cancers.
Liao HF; Lee HH; Chang YS; Lin CL; Liu TY; Chen YC; Yen JC; Lee YT; Lin CY; Wu SH; Ko YC; Chang JG
Sci Rep; 2016 Jun; 6():27350. PubMed ID: 27283888
[TBL] [Abstract][Full Text] [Related]
2. ALPK1 genetic regulation and risk in relation to gout.
Ko AM; Tu HP; Liu TT; Chang JG; Yuo CY; Chiang SL; Chang SJ; Liu YF; Ko AM; Lee CH; Lee CP; Chang CM; Tsai SF; Ko YC
Int J Epidemiol; 2013 Apr; 42(2):466-74. PubMed ID: 23569188
[TBL] [Abstract][Full Text] [Related]
3. FAM83D knockdown regulates proliferation, migration and invasion of colorectal cancer through inhibiting FBXW7/Notch-1 signalling pathway.
Mu Y; Zou H; Chen B; Fan Y; Luo S
Biomed Pharmacother; 2017 Jun; 90():548-554. PubMed ID: 28407575
[TBL] [Abstract][Full Text] [Related]
4. Arl4c expression in colorectal and lung cancers promotes tumorigenesis and may represent a novel therapeutic target.
Fujii S; Matsumoto S; Nojima S; Morii E; Kikuchi A
Oncogene; 2015 Sep; 34(37):4834-44. PubMed ID: 25486429
[TBL] [Abstract][Full Text] [Related]
5. ALPK1 phosphorylates myosin IIA modulating TNF-α trafficking in gout flares.
Lee CP; Chiang SL; Ko AM; Liu YF; Ma C; Lu CY; Huang CM; Chang JG; Kuo TM; Chen CL; Tsai EM; Ko YC
Sci Rep; 2016 May; 6():25740. PubMed ID: 27169898
[TBL] [Abstract][Full Text] [Related]
6. ERN1 and ALPK1 inhibit differentiation of bi-potential tumor-initiating cells in human breast cancer.
Strietz J; Stepputtis SS; Preca BT; Vannier C; Kim MM; Castro DJ; Au Q; Boerries M; Busch H; Aza-Blanc P; Heynen-Genel S; Bronsert P; Kuster B; Stickeler E; Brabletz T; Oshima RG; Maurer J
Oncotarget; 2016 Dec; 7(50):83278-83293. PubMed ID: 27829216
[TBL] [Abstract][Full Text] [Related]
7. Low Expression of DYRK2 (Dual Specificity Tyrosine Phosphorylation Regulated Kinase 2) Correlates with Poor Prognosis in Colorectal Cancer.
Yan H; Hu K; Wu W; Li Y; Tian H; Chu Z; Koeffler HP; Yin D
PLoS One; 2016; 11(8):e0159954. PubMed ID: 27532268
[TBL] [Abstract][Full Text] [Related]
8. Endoplasmic reticulum ribosome-binding protein 1 (RRBP1) overexpression is frequently found in lung cancer patients and alleviates intracellular stress-induced apoptosis through the enhancement of GRP78.
Tsai HY; Yang YF; Wu AT; Yang CJ; Liu YP; Jan YH; Lee CH; Hsiao YW; Yeh CT; Shen CN; Lu PJ; Huang MS; Hsiao M
Oncogene; 2013 Oct; 32(41):4921-31. PubMed ID: 23318453
[TBL] [Abstract][Full Text] [Related]
9. ALPK1 affects testosterone mediated regulation of proinflammatory cytokines production.
Kuo TM; Yeh KT; Hsu HT; Chiang SL; Chang JG; Huang CM; Tu HP; Liu CS; Ko YC
J Steroid Biochem Mol Biol; 2015 Nov; 154():150-8. PubMed ID: 26275947
[TBL] [Abstract][Full Text] [Related]
10. Gain-of-function mutant p53 upregulates CXC chemokines and enhances cell migration.
Yeudall WA; Vaughan CA; Miyazaki H; Ramamoorthy M; Choi MY; Chapman CG; Wang H; Black E; Bulysheva AA; Deb SP; Windle B; Deb S
Carcinogenesis; 2012 Feb; 33(2):442-51. PubMed ID: 22114072
[TBL] [Abstract][Full Text] [Related]
11. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
[TBL] [Abstract][Full Text] [Related]
12. Cellular apoptosis susceptibility (chromosome segregation 1-like, CSE1L) gene is a key regulator of apoptosis, migration and invasion in colorectal cancer.
Alnabulsi A; Agouni A; Mitra S; Garcia-Murillas I; Carpenter B; Bird S; Murray GI
J Pathol; 2012 Dec; 228(4):471-81. PubMed ID: 22450763
[TBL] [Abstract][Full Text] [Related]
13. Gain-of-function mutations in
Kozycki CT; Kodati S; Huryn L; Wang H; Warner BM; Jani P; Hammoud D; Abu-Asab MS; Jittayasothorn Y; Mattapallil MJ; Tsai WL; Ullah E; Zhou P; Tian X; Soldatos A; Moutsopoulos N; Kao-Hsieh M; Heller T; Cowen EW; Lee CR; Toro C; Kalsi S; Khavandgar Z; Baer A; Beach M; Long Priel D; Nehrebecky M; Rosenzweig S; Romeo T; Deuitch N; Brenchley L; Pelayo E; Zein W; Sen N; Yang AH; Farley G; Sweetser DA; Briere L; Yang J; de Oliveira Poswar F; Schwartz IVD; Silva Alves T; Dusser P; Koné-Paut I; Touitou I; Titah SM; van Hagen PM; van Wijck RTA; van der Spek PJ; Yano H; Benneche A; Apalset EM; Jansson RW; Caspi RR; Kuhns DB; Gadina M; Takada H; Ida H; Nishikomori R; Verrecchia E; Sangiorgi E; Manna R; Brooks BP; Sobrin L; Hufnagel RB; Beck D; Shao F; Ombrello AK; Aksentijevich I; Kastner DL;
Ann Rheum Dis; 2022 Oct; 81(10):1453-1464. PubMed ID: 35868845
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-19a functions as an oncogenic microRNA in non-small cell lung cancer by targeting the suppressor of cytokine signaling 1 and mediating STAT3 activation.
Wang X; Chen Z
Int J Mol Med; 2015 Mar; 35(3):839-46. PubMed ID: 25604748
[TBL] [Abstract][Full Text] [Related]
15. miR-204-5p inhibits proliferation and invasion and enhances chemotherapeutic sensitivity of colorectal cancer cells by downregulating RAB22A.
Yin Y; Zhang B; Wang W; Fei B; Quan C; Zhang J; Song M; Bian Z; Wang Q; Ni S; Hu Y; Mao Y; Zhou L; Wang Y; Yu J; Du X; Hua D; Huang Z
Clin Cancer Res; 2014 Dec; 20(23):6187-99. PubMed ID: 25294901
[TBL] [Abstract][Full Text] [Related]
16. Hsa-mir-182 suppresses lung tumorigenesis through down regulation of RGS17 expression in vitro.
Sun Y; Fang R; Li C; Li L; Li F; Ye X; Chen H
Biochem Biophys Res Commun; 2010 May; 396(2):501-7. PubMed ID: 20420807
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic function of a novel WD-domain protein, STRAP, in human carcinogenesis.
Halder SK; Anumanthan G; Maddula R; Mann J; Chytil A; Gonzalez AL; Washington MK; Moses HL; Beauchamp RD; Datta PK
Cancer Res; 2006 Jun; 66(12):6156-66. PubMed ID: 16778189
[TBL] [Abstract][Full Text] [Related]
18. NLK, a novel target of miR-199a-3p, functions as a tumor suppressor in colorectal cancer.
Han Y; Kuang Y; Xue X; Guo X; Li P; Wang X; Guo X; Yuan B; Zhi Q; Zhao H
Biomed Pharmacother; 2014 Jun; 68(5):497-505. PubMed ID: 24972723
[TBL] [Abstract][Full Text] [Related]
19. High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases.
Kato H; Semba S; Miskad UA; Seo Y; Kasuga M; Yokozaki H
Clin Cancer Res; 2004 Nov; 10(21):7318-28. PubMed ID: 15534108
[TBL] [Abstract][Full Text] [Related]
20. Protocadherin 10 suppresses tumorigenesis and metastasis in colorectal cancer and its genetic loss predicts adverse prognosis.
Jao TM; Tsai MH; Lio HY; Weng WT; Chen CC; Tzeng ST; Chang CY; Lai YC; Yen SJ; Yu SL; Yang YC
Int J Cancer; 2014 Dec; 135(11):2593-603. PubMed ID: 24740680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
